tirzepatide weight loss compared to semaglutide GLP-1 vs for in Adults Comparative weight-loss response profiles and

Abrupt discontinuation without a management plan may result in weight regain and deterioration of glycemic control in individuals with diabetes

At 5 mg in SURMOUNT-1, 24.6% of participants reported nausea, 18.7% diarrhea, 8.3% vomiting, and 16.8% constipation

If You Take Medication for Hypothyroidism Do you feel ashamed that you need thyroid hormone replacement

Gastrointestinal side effects may be compounded

If its within 4 days (96 hours) of the scheduled time: inject it immediately If its after 4 days : skip and wait for the next scheduled dose Never take two doses within 72 hours Mounjaros active ingredient, tirzepatide , is a synthetic peptide that activates two hormone receptors simultaneously : GIP (Glucose-dependent Insulinotropic Polypeptide) Stimulates insulin release after meals Improves the bodys response to insulin Reduces fat storage by improving lipid metabolism Enhances the effectiveness of GLP-1 GLP-1 (Glucagon-like Peptide-1) Suppresses appetite via brain signaling (hypothalamus) Slows gastric emptying keeps you full longer Reduces glucagon (a hormone that raises blood sugar) Promotes weight loss and lowers blood sugar In Summary: Mounjaro mimics natural gut hormones but in a much stronger and longer-acting form , resetting the metabolic system, curbing hunger, improving insulin use, and accelerating fat loss